Business Context and Reporting Period
Company: Universe Pharmaceuticals INC
Filing Type: Form 6-K (Report of Foreign Private Issuer)
Date: August 26, 2025
Subject: Adjournment of the 2025 Annual General Meeting due to lack of quorum.
Financial Metrics
The filing text does not provide a clear value for revenue, profit, cash flow, margins, debt, or liquidity. This report is a procedural notice regarding a shareholder meeting and contains no financial data.
Material Changes
No material financial changes are reported. The only material event is the procedural adjournment of the Annual General Meeting originally scheduled for August 26, 2025.
Guidance, Outlook, and Management Commentary
- Meeting Status: The 2025 Annual General Meeting was adjourned because a quorum was not achieved.
- Rescheduled Date: September 2, 2025.
- Rescheduled Time: 10:00 a.m., Beijing Time.
- Location: 265 Jingjiu Avenue, Jinggangshan Economy and Technology Development Zone, Ji'an City, Jiangxi 343100, China.
Key Facts for Investor Verification
- Verify the rescheduled meeting date of September 2, 2025, to ensure participation or proxy voting.
- Confirm whether the lack of quorum indicates low shareholder engagement or specific logistical issues.
- Monitor future filings for the actual results of the adjourned meeting, including any proposed resolutions or financial reports that were intended for discussion.